Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2015-07-02 (10 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: PLONEVEZ-DU-FAOU (29530), Finistere
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE PLONEVEZ : revenue, balance sheet and financial ratios
PHARMACIE DE PLONEVEZ is a French company
founded 10 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PLONEVEZ-DU-FAOU (29530),
this company of category PME
shows in 2016 a revenue of 2.1 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE PLONEVEZ (SIREN 812371862)
Indicator
2019
2018
2016
Revenue
N/C
N/C
2 135 943 €
Net income
189 998 €
190 646 €
105 262 €
EBITDA
N/C
N/C
198 065 €
Net margin
N/C
N/C
4.9%
Revenue and income statement
In 2019, PHARMACIE DE PLONEVEZ generates positive net income of 190 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2019: 105 k€ -> 190 k€.
Net income (2019)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
189 998 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 208%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 29%. The balance between equity and debt is satisfactory.
Debt ratio (2019)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
208.145%
Financial autonomy (2019)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
29.221%
Asset age ratio (2019)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE PLONEVEZ
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2018
2019
Debt ratio
607.316
317.652
208.145
Financial autonomy
12.819
21.177
29.221
Repayment capacity
11.928
None
None
Cash flow / Revenue
6.067%
None%
None%
Sector positioning
Debt ratio
208.152019
2016
2018
2019
Q1: 35.68
Med: 104.11
Q3: 243.61
Average-6 pts over 3 years
In 2019, the debt ratio of PHARMACIE DE PLONEVEZ (208.15) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
29.22%2019
2016
2018
2019
Q1: 22.98%
Med: 40.68%
Q3: 60.84%
Average+9 pts over 3 years
In 2019, the financial autonomy of PHARMACIE DE PLONEVEZ (29.2%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
11.93 years2016
2016
Q1: 2.17 years
Med: 6.32 years
Q3: 11.13 years
Average
In 2016, the repayment capacity of PHARMACIE DE PLONEVEZ (11.93) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 268.64. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2019)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
268.644
Liquidity indicators evolution PHARMACIE DE PLONEVEZ
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2018
2019
Liquidity ratio
147.437
206.155
268.644
Interest coverage
15.519
None
None
Sector positioning
Liquidity ratio
268.642019
2016
2018
2019
Q1: 119.99
Med: 167.03
Q3: 236.26
Excellent+30 pts over 3 years
In 2019, the liquidity ratio of PHARMACIE DE PLONEVEZ (268.64) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
15.52x2016
2016
Q1: 4.69x
Med: 10.82x
Q3: 19.32x
Good
In 2016, the interest coverage of PHARMACIE DE PLONEVEZ (15.5x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2019)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2019)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2019)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2019)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE PLONEVEZ
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2018
2019
Operating WCR
153 980 €
0 €
0 €
Inventory turnover (days)
32
0
0
Customer payment term (days)
6
0
0
Supplier payment term (days)
20
0
0
Positioning of PHARMACIE DE PLONEVEZ in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 205 transactions of similar company sales
in 2019,
the value of PHARMACIE DE PLONEVEZ is estimated at
2 361 338 €
(range 1 406 551€ - 3 351 865€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2019
205 transactions
1406k€2361k€3351k€
2 361 338 €Range: 1 406 551€ - 3 351 865€
NAF 5 année 2019
Valuation method used
Net Income Multiple
189 998 €
×
12.4x
=2 361 339 €
Range: 1 406 551€ - 3 351 866€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 205 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE PLONEVEZ with other companies in the same sector:
Frequently asked questions about PHARMACIE DE PLONEVEZ
What is the revenue of PHARMACIE DE PLONEVEZ ?
The revenue of PHARMACIE DE PLONEVEZ in 2016 is 2.1 M€.
Is PHARMACIE DE PLONEVEZ profitable?
Yes, PHARMACIE DE PLONEVEZ generated a net profit of 190 k€ in 2019.
Where is the headquarters of PHARMACIE DE PLONEVEZ ?
The headquarters of PHARMACIE DE PLONEVEZ is located in PLONEVEZ-DU-FAOU (29530), in the department Finistere.
Where to find the tax return of PHARMACIE DE PLONEVEZ ?
The tax return of PHARMACIE DE PLONEVEZ is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE PLONEVEZ operate?
PHARMACIE DE PLONEVEZ operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart